Enteric diseases are caused by microscopic pathogens that enter the body through the mouth or intestinal route, fundamentally because of eating or drinking contaminated foods or fluids. The immune system of the body and the strength of the pathogen together determine the fate of the infection, whether it will be acute or chronic. The enteric pathogen can cause further complexities, such as malabsorption of medications and immunological disorders. Abdominal cramps, loss of appetite, vomiting, diarrhea, blood in the stools, fever, and dehydration are a few of the key symptoms of any enteric disease.
An enteric infection has an intense effect on childhood development and global mortality as well. According to the Centers for Disease Control and Prevention, the enteric disease is a serious public health issue that causes around 48 million cases of illness each year and whose treatment costs US$125 billion each year only in the United States. The global enteric disease testing market can be divided into three categories based on pathogen type: viral pathogens, bacterial pathogens, and parasitic pathogens. On the basis of test type, the global enteric disease testing market can be segmented into immunological tests, molecular diagnostic tests, rapid tests, culture tests, and other tests.
Financial and ecological factors, for example, such as poor sanitation and a rising population living below the poverty line with an unhygienic lifestyle and contaminated foods and water supplies, contribute to the rising incidences of enteric diseases, which in turn impel the enteric disease testing market's development. Technological advancements for enteric disease testing, with the huge adoption rate of rapid tests along with immunological and molecular test platforms, propel the growth of the enteric disease testing market. Organizations like UNICEF or WHO have taken a few initiatives for enteric disease management that have contributed to the growth of the enteric disease testing market as well. The lack of awareness in public, poor financial conditions, improper laboratory set-up, and untrained health personnel in developing countries restrain the growth of the enteric disease testing market.
Because of its well-organized healthcare infrastructure and high healthcare expenditure, North America is expected to dominate the enteric disease testing market. Large populations, rising prevalence of enteric diseases, unhealthy lifestyles, improper sanitation, and poor economic conditions all positively influence the growth of the enteric disease testing market in the Asia-Pacific region.
The global enteric disease testing market is classified as follows:
Revenue (US$ Mn) of the Global Enteric Disease Testing Market by Infection Type, 2015-2025
Viral Infections
Bacterial Infections
Parasitic Infections
Revenue (US$ Mn) of the Global Enteric Disease Testing Market by Test Type, 2015-2025
Immunologic test
Molecular diagnostic test
Rapid test
Culture test
Other tests
Revenue (US$ Mn) of the Global Enteric Disease Testing Market by Geography, 2015-2025
North America
US
Canada
Europe
UK
Germany
Rest of Europe
Asia-Pacific
Japan
China
Rest of APAC
Latin America
Brazil
Mexico
Rest of LATAM
Middle East and Africa
GCC
South Africa
the remainder of MEA
Key players identified for the enteric disease testing market include:
A few major players in the enteric disease testing market include Alere Inc., Bio-Rad Laboratories, Quest Diagnostics, Becton Dickinson and Company, Cepheid, DiaSorin, Meridian BioSciences, Trinity Biotech, and Coris BoConcept.
This report offers the following:
An overview of the global markets for enteric disease testing
Market trends assessment for the period 2015-2025, including historical data for 2015 and projections through 2025, as well as respective CAGRs from 2017 to 2025.
Qualitative assessment tools such as market drivers, challenges, and future prospects
Market competition examination tools such as market share analysis and fractal map evaluation
Focus on each level of market segmentation based on product approvals, launches, and current and anticipated market dynamics.
A general overview of the industry structure.
Company profiles highlighting key information about the major players operating in the enteric disease testing market
Frequently Asked Question:
The market for Enteric Disease Testing Market is expected to reach USD$ XX Mn in 2025.
The Enteric Disease Testing Market is expected to see significant CAGR growth over the coming years, at XX%.
The report is forecasted from 2015-2025.
The base year of this report is 2014.
Alere Inc., Bio-Rad Laboratories, Quest Diagnostics, Becton Dickinson and Company, Cepheid.are some of the major players in the global market.
